• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    PowerUp Acquisition Corp. Announces Postponement of Extraordinary General Meeting of Shareholders

    5/16/24 4:05:00 PM ET
    $PWUP
    Blank Checks
    Finance
    Get the next $PWUP alert in real time by email

    New York, NY, May 16, 2024 (GLOBE NEWSWIRE) -- PowerUp Acquisition Corp. (the "Company") (NASDAQ:PWUP) announced today that its extraordinary general meeting of shareholders (the "Meeting"), which was originally scheduled for May 17, 2024, has been postponed to 9:00 a.m. Eastern Time, on Tuesday, May 21, 2024. At the Meeting, the Company's shareholders will be asked to vote on a proposal to approve, among other things, extending the date by which the Company must consummate an initial business combination from May 23, 2024 to February 17, 2025. There are no changes to the location, record date, purpose or any of the proposals to be acted upon at the Meeting.

    As a result of this change, the Meeting will now be held at 9:00 a.m. Eastern Time on Tuesday, May 21, 2024, and the Company has extended the deadline for holders of its ordinary shares to submit their publicly held shares for redemption to 5:00 p.m. Eastern Time on Friday, May 17, 2024. Shareholders who wish to withdraw their previously submitted redemption requests may do so by contacting the Company's transfer agent prior to this deadline.

    If shareholders have any questions or need assistance, please contact the Company's proxy solicitor, Issuer Direct Corporation, at:

    Issuer Direct Corporation

    One Glenwood Ave, Suite 1001

    Raleigh, NC 27603

    (919) 481-4000

    [email protected]

    About PowerUp Acquisition Corp.

    PowerUp Acquisition Corp. is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The management team is led by Mr. Surendra Ajjarapu, Chief Executive Officer.

    Advisors

    Dykema Gossett, PLLC serves as legal counsel to PowerUp Acquisition Corp.

    Participants in the Solicitation

    The Company and its directors, executive officers, other members of management and employees may be deemed participants in the solicitation of proxies from the Company's shareholders with respect to the Meeting, the proposals, and related matters. Information regarding the Company's directors and executive officers is available in Company's Definitive Proxy Statement on Schedule 14A filed by the Company with the U.S. Securities and Exchange Commission (the "SEC") on April 26, 2024 (the "Proxy Statement"). Additional information regarding the participants in the proxy solicitation and a description of their direct and indirect interests are contained in the Proxy Statement.

    No Offer or Solicitation

    This communication shall not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any jurisdiction in which the offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such jurisdiction. No offering of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended.

    Additional Information

    The Company has filed a Proxy Statement with the SEC in connection with the Meeting and, beginning on or about May 1, 2024, mailed the Proxy Statement and other relevant documents to its shareholders as of the April 2, 2024 record date for the Meeting. The Company's shareholders and other interested persons are advised to read the Proxy Statement and any other relevant documents that have been or will be filed with the SEC in connection with the Company's solicitation of proxies for the Meeting because these documents contain important information about the Company, the proposals, and related matters. Shareholders may also obtain a free copy of the Proxy Statement, as well as other relevant documents that have been or will be filed with the SEC, without charge, at the SEC's website located at www.sec.gov or by directing a request to: PowerUp Acquisition Corp., 188 Grand Street Unit #195, New York, NY 10013, Attention: Mr. Suren Ajjarapu.

    Forward-Looking Statements

    This press release includes "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Statements regarding the meeting and related matters, as well as all other statements other than statements of historical fact included in this press release are forward-looking statements. When used in this press release, words such as "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "might," "plan," "possible," "potential," "predict," "project," "should," "would" and similar expressions, as they relate to us or our management team, identify forward-looking statements. Such forward-looking statements are based on the beliefs of management, as well as assumptions made by, and information currently available to, the Company's management. Actual results could differ materially from those contemplated by the forward-looking statements as a result of certain factors detailed in the Company's filings with the SEC. All subsequent written or oral forward-looking statements attributable to the Company or persons acting on its behalf are qualified in their entirety by this paragraph. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the "Risk Factors" section of the Company's Annual Report on Form 10-K, subsequent quarterly reports on Form 10-Q and initial public offering prospectus. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.

    Corporate Contact:

    Suren Ajjarapu

    Chairman and Chief Executive Officer

    [email protected]

    347-313-8109



    Primary Logo

    Get the next $PWUP alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $PWUP

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $PWUP
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Aspire Biopharma, Inc., and PowerUp Acquisition Corp. Announce Business Combination Agreement to Create Nasdaq-listed Biopharmaceutical Company Driving Breakthrough Innovations in FDA Approved Drugs, Nutraceuticals and Supplements

    Highlights Transaction Valuation: The transaction values Aspire Biopharma, Inc. at a pre-money equity value of approximately $316 million.Industry-Leading Platform: Aspire is focused on developing a pipeline of products utilizing its novel delivery mechanisms to enhance the efficacy of "do no harm" FDA approved drugs, nutraceuticals and supplements.Innovative Drug Delivery Technology: Aspire's patented and patent-pending delivery system includes components specifically formulated to allow rapid sublingual absorption of drugs directly into the blood stream, thus on first pass, avoiding the gastrointestinal tract and liver, mitigating unwanted toxicity of this critical organ.Growth and

    9/3/24 8:01:00 AM ET
    $PWUP
    Blank Checks
    Finance

    Aspire Biopharma, Inc. Signs Letter of Intent to Create a Publicly Listed, Drug Delivery Company Through a Business Combination with PowerUp Acquisition Corp.

    Humacao, PR and New York, NY, July 31, 2024 (GLOBE NEWSWIRE) -- Aspire Biopharma, Inc. ("Aspire" or the "Company"), a developer of a multi-faceted patent protected disruptive drug delivery mechanism technology, and PowerUp Acquisition Corp. (NASDAQ:PWUP), a Nasdaq Global Market® listed special purpose acquisition company ("PowerUp"), today announced that they have signed a non-binding letter of intent ("LOI") for a potential business combination ("Business Combination"). Under the terms of the LOI, following the consummation of the Business Combination, the combined public company would be listed on a national securities exchange. Aspire Biopharma, Inc. is a privately held, early-stag

    7/31/24 8:01:00 AM ET
    $PWUP
    Blank Checks
    Finance

    PowerUp Acquisition Corp. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q

    New York, NY, June 05, 2024 (GLOBE NEWSWIRE) -- PowerUp Acquisition Corp. (the "Company") (NASDAQ:PWUP) announced today that, on June 3, 2024, the Company received a notice (the "Notice") from the Nasdaq Listing Qualifications Department ("Nasdaq") indicating that the Company was not compliant with the timely filing requirement for continued listing under Nasdaq Listing Rule 5250(c)(1) (the "Listing Rule"), which requires listed companies to timely file all required periodic reports with the Securities and Exchange Commission ("SEC"). The Notice indicates that the Company must, no later than August 2, 2024, submit a plan to regain compliance with respect to the filing requirement. Followi

    6/5/24 4:05:00 PM ET
    $PWUP
    Blank Checks
    Finance

    $PWUP
    SEC Filings

    View All

    SEC Form SCHEDULE 13G filed by PowerUp Acquisition Corp.

    SCHEDULE 13G - Aspire Biopharma Holdings, Inc. (0001847345) (Subject)

    2/26/25 9:20:28 PM ET
    $PWUP
    Blank Checks
    Finance

    PowerUp Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Changes in Control of Registrant, Leadership Update, Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics, Change in Shell C

    8-K - Aspire Biopharma Holdings, Inc. (0001847345) (Filer)

    2/21/25 4:59:21 PM ET
    $PWUP
    Blank Checks
    Finance

    PowerUp Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Aspire Biopharma Holdings, Inc. (0001847345) (Filer)

    2/20/25 4:45:33 PM ET
    $PWUP
    Blank Checks
    Finance

    $PWUP
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Doshi Mayur Mansukhlal

    3 - PowerUp Acquisition Corp. (0001847345) (Issuer)

    8/28/23 5:00:32 PM ET
    $PWUP
    Blank Checks
    Finance

    SEC Form 3 filed by new insider Wadhwani Avinash R

    3 - PowerUp Acquisition Corp. (0001847345) (Issuer)

    8/28/23 5:00:26 PM ET
    $PWUP
    Blank Checks
    Finance

    SEC Form 3: New insider Ajjarapu Surendra K claimed ownership of 4,317,500 units of Class A Ordinary Shares

    3 - PowerUp Acquisition Corp. (0001847345) (Issuer)

    8/28/23 5:00:39 PM ET
    $PWUP
    Blank Checks
    Finance

    $PWUP
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by PowerUp Acquisition Corp.

    SC 13G/A - PowerUp Acquisition Corp. (0001847345) (Subject)

    7/30/24 10:56:11 AM ET
    $PWUP
    Blank Checks
    Finance

    SEC Form SC 13G filed by PowerUp Acquisition Corp.

    SC 13G - PowerUp Acquisition Corp. (0001847345) (Subject)

    5/28/24 7:58:56 AM ET
    $PWUP
    Blank Checks
    Finance

    SEC Form SC 13G/A filed by PowerUp Acquisition Corp. (Amendment)

    SC 13G/A - PowerUp Acquisition Corp. (0001847345) (Subject)

    2/14/24 9:33:46 AM ET
    $PWUP
    Blank Checks
    Finance